Meningeal lymphatics affect microglia responses and anti-Aβ immunotherapy

S Da Mesquita, Z Papadopoulos, T Dykstra, L Brase… - Nature, 2021 - nature.com
Alzheimer's disease (AD) is the most prevalent cause of dementia. Although there is no
effective treatment for AD, passive immunotherapy with monoclonal antibodies against …

Meningeal lymphatics affect microglia responses and anti-Aβ immunotherapy

S Mesquita, Z Papadopoulos, T Dykstra, L Brase… - Nature, 2021 - econpapers.repec.org
Alzheimer's disease (AD) is the most prevalent cause of dementia1. Although there is no
effective treatment for AD, passive immunotherapy with monoclonal antibodies against …

[PDF][PDF] Meningeal lymphatics affect microglia responses and anti-Aβ immunotherapy

S Da Mesquita, Z Papadopoulos, T Dykstra, L Brase… - 2021 - scholarworks.iupui.edu
Alzheimer's disease (AD) is the most prevalent cause of dementia1. Although there is no
effective treatment for AD, passive immunotherapy with monoclonal antibodies against …

Meningeal lymphatics affect microglia responses and anti-Aβ immunotherapy

S Mesquita, Z Papadopoulos, T Dykstra, L Brase… - Nature, 2021 - ideas.repec.org
Alzheimer's disease (AD) is the most prevalent cause of dementia1. Although there is no
effective treatment for AD, passive immunotherapy with monoclonal antibodies against …

Meningeal lymphatics affect microglia responses and anti-Aβ immunotherapy.

S Da Mesquita, Z Papadopoulos, T Dykstra, L Brase… - Nature, 2021 - europepmc.org
Alzheimer's disease (AD) is the most prevalent cause of dementia. While there is no effective
treatment for AD, passive immunotherapy with monoclonal antibodies against amyloid beta …

Meningeal lymphatics affect microglia responses and anti-Aβ immunotherapy

S Da Mesquita, Z Papadopoulos, T Dykstra, L Brase… - paper.sciencenet.cn
近日, 美国维吉尼亚大学Jonathan Kipnis, Sandro Da Mesquita 等研究人员合作发现,
脑膜淋巴管影响小胶质细胞反应和抗Aβ 免疫疗法. 相关论文于2021 年4 月28 …

Meningeal lymphatics affect microglia responses and anti-Aβ immunotherapy

S Da Mesquita, Z Papadopoulos, T Dykstra… - …, 2021 - pubmed.ncbi.nlm.nih.gov
Alzheimer's disease (AD) is the most prevalent cause of dementia 1. Although there is no
effective treatment for AD, passive immunotherapy with monoclonal antibodies against …

Meningeal lymphatics affect microglia responses and anti-Aβ immunotherapy

J Herz, I Smirnov, BA Benitez, CM Karch, RJ Perrin… - Nature, 2021 - profiles.wustl.edu
Alzheimer's disease (AD) is the most prevalent cause of dementia 1. Although there is no
effective treatment for AD, passive immunotherapy with monoclonal antibodies against …

Meningeal lymphatics affect microglia responses and anti-Aβ immunotherapy

Dominantly Inherited Alzheimer Network - Nature, 2021 - mayoclinic.elsevierpure.com
Alzheimer's disease (AD) is the most prevalent cause of dementia 1. Although there is no
effective treatment for AD, passive immunotherapy with monoclonal antibodies against …

Meningeal lymphatics affect microglia responses and anti-Aβ immunotherapy

S Da Mesquita, Z Papadopoulos, T Dykstra, L Brase… - 2021 - scholarworks.iupui.edu
Alzheimer's disease (AD) is the most prevalent cause of dementia1. Although there is no
effective treatment for AD, passive immunotherapy with monoclonal antibodies against …